Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Dec;2(6):495–501. doi: 10.1111/j.1365-2125.1975.tb00566.x

Effect of intravenous injection of salbutamol in asthma.

C S May, J W Paterson, S G Spiro, A J Johnson
PMCID: PMC1402639  PMID: 1234013

Abstract

The effect of i.v. salbutamol was compared with aerosol salbutamol in ten asthmatic patients. 2 A cumulative dose of salbutamol (300 mug) given in three separate injections over 45 min resulted in a mean increase in peak expiratory flow rate (PEFR) of 38.3% and FEV1 of 36%. 3 There was no significant difference in degree of bronchodilatation to the same dose of salbutamol administered intravenously or by aerosol. 4 Palpitations, tremor, and postural hypotension were common when the drug was injected intravenously over one minute, but did not occur after aerosol administration. 5 It is suggested that sulbutamol by intravenous injection is a useful addition to the treatment of acute asthma.

Full text

PDF
496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fitchett D. H., McNicol M. W., Riordan J. F. Intravenous salbutamol in management of status asthmaticus. Br Med J. 1975 Jan 11;1(5949):53–55. doi: 10.1136/bmj.1.5949.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gibson D. G., Coltart D. J. Haemodynamic effects of intravenous salbutamol in patients with mitral valve disease: comparison with isoprenaline and atropine. Postgrad Med J. 1971 Mar;47(Suppl):40–44. [PubMed] [Google Scholar]
  3. Kennedy M. C., Simpson W. T. Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator. Br J Dis Chest. 1969 Jul;63(3):165–174. doi: 10.1016/s0007-0971(69)80014-8. [DOI] [PubMed] [Google Scholar]
  4. Paterson J. W., Evans R. J., Prime F. J. SElectivity of broncholidlator action of salbutamol in asthmatic patients. Br J Dis Chest. 1971 Jan;65(1):21–38. [PubMed] [Google Scholar]
  5. Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):861–867. doi: 10.1002/cpt1972136861. [DOI] [PubMed] [Google Scholar]
  6. Warrell D. A., Robertson D. G., Howes J. N., Conolly M. E., Paterson J. W., Beilin L. J., Dollery C. T. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J. 1970 Jan 10;1(5688):65–70. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES